Jun Muto1, Hiroshi Kishimoto2, Yasuo Kaizuka3, Mitsuru Kinjo4, Hidefumi Higashi5, Fumiaki Kishihara5. 1. Department of Surgery, Steel Memorial Yawata Hospital, Kitakyushu, Japan muto@surg2.med.kyushu-u.ac.jp. 2. Department of Nephrology, Steel Memorial Yawata Hospital, Kitakyushu, Japan. 3. Intensive Care Unit, Steel Memorial Yawata Hospital, Kitakyushu, Japan. 4. Department of Pathology, Steel Memorial Yawata Hospital, Kitakyushu, Japan. 5. Department of Surgery, Steel Memorial Yawata Hospital, Kitakyushu, Japan.
Abstract
BACKGROUND: Thrombotic microangiopathy (TMA) represents a spectrum of serious disorders characterized by occlusive microvascular thrombosis, thrombocytopenia and end-organ damage. TMA is associated with a broad range of conditions and is also a well-described complication of both cancer and its treatment. CASE REPORT: A 77-year-old Japanese woman underwent S-1 and cisplatin chemotherapy for treatment of advanced gastric cancer with multiple lymph node and liver metastases. She was found with severe anemia and thrombocytopenia during the third course of chemotherapy. She was diagnosed with TMA based on thrombocytopenia, schistocytosis, hemolytic anemia and renal dysfunction. She underwent treatment with plasmapheresis; however, her response to treatment was poor and died on day 16 of hospitalization. The autopsy performed revealed microthrombi in the glomeruli and tubulonecrosis in the kidneys. CONCLUSION: This is the first case report of TMA in association with the use of S-1 and cisplatin. Therapists have to take account of TMA when using S-1 and cisplatin treatment. Copyright
BACKGROUND:Thrombotic microangiopathy (TMA) represents a spectrum of serious disorders characterized by occlusive microvascular thrombosis, thrombocytopenia and end-organ damage. TMA is associated with a broad range of conditions and is also a well-described complication of both cancer and its treatment. CASE REPORT: A 77-year-old Japanese woman underwent S-1 and cisplatin chemotherapy for treatment of advanced gastric cancer with multiple lymph node and liver metastases. She was found with severe anemia and thrombocytopenia during the third course of chemotherapy. She was diagnosed with TMA based on thrombocytopenia, schistocytosis, hemolytic anemia and renal dysfunction. She underwent treatment with plasmapheresis; however, her response to treatment was poor and died on day 16 of hospitalization. The autopsy performed revealed microthrombi in the glomeruli and tubulonecrosis in the kidneys. CONCLUSION: This is the first case report of TMA in association with the use of S-1 and cisplatin. Therapists have to take account of TMA when using S-1 and cisplatin treatment. Copyright
Authors: Pavan K Bendapudi; Ang Li; Ayad Hamdan; Lynne Uhl; Richard Kaufman; Christopher Stowell; Walter Dzik; Robert S Makar Journal: Br J Haematol Date: 2015-08-28 Impact factor: 6.998
Authors: M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle Journal: N Engl J Med Date: 1998-11-26 Impact factor: 91.245
Authors: J B Lesesne; N Rothschild; B Erickson; S Korec; R Sisk; J Keller; M Arbus; P V Woolley; L Chiazze; P S Schein Journal: J Clin Oncol Date: 1989-06 Impact factor: 44.544